PregaNews, India’s No.1 pregnancy detection brand, by Mankind Pharma, trusted by millions of women and gynaecologists, has launched a new digital film ahead of International Women’s Day to encourage open conversations around postpartum experiences, a phase often overlooked despite being one of the most emotionally and physically demanding periods in a woman’s life.
In India, nearly one in five mothers experience postpartum depression, yet many continue to struggle in silence, often hesitant to seek help due to fear of judgment or misunderstanding. The campaign film sensitively highlights how postpartum struggles are frequently normalised in everyday conversations, with new mothers often expected to accept discomfort, emotional challenges, and exhaustion as part of the journey without expressing their true feelings. Through relatable moments and authentic storytelling, the film aims to create a more supportive environment where women feel comfortable sharing their experiences without hesitation or judgment.
The initiative reflects PregaNews’ continued commitment to supporting women beyond pregnancy, recognising motherhood as a journey that includes emotional wellbeing alongside physical health.
Commenting on the campaign, Joy Chatterjee, Vice President and Head of Sales and Marketing for Consumer Division, Mankind Pharma, said: “At PregaNews, we believe that supporting women goes beyond pregnancy detection. Motherhood is a deeply personal journey, and every woman deserves understanding and empathy during this transformative phase. Through this campaign, we hope to encourage meaningful conversations around postpartum experiences and help create an environment where women feel heard, supported and reassured.”
The film was conceptualized and executed by Shweta Bhuchar Co-Founder & Producer and Gaurav Bhardwaj, Co-Founder & Director, SG Dream Media, with a focus on portraying the quiet realities many new mothers face but rarely articulate.
With this Women’s Day initiative, PregaNews continues to expand its role from being a trusted pregnancy detection brand to becoming a partner in women’s health conversations, addressing not just milestones, but the realities that follow them.
The campaign film is now live across PregaNews’ digital platforms.
https://www.instagram.com/reel/DVF0OvGDIGw/?igsh=a2xia3V0dWx0a2Uy
https://www.youtube.com/watch?v=nNhK5EDkNCA
About Mankind Pharma
Mankind Pharma (BSE: 543904 | NSE: MANKIND) is one of the largest pharmaceutical company in India, which focuses on the domestic market with its Pan India presence. Mankind operates at the intersection of the Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices. The company is a leading player in the domestic pharmaceuticals business present across acute and chronic therapeutic areas including anti-infectives, cardiovascular, gastrointestinal, antidiabetic, neuro/CNS, gynecology, VMN and respiratory, among others with a strategy to increase chronic presence going ahead. In the consumer healthcare business, the company operates in condoms, pregnancy detection, emergency contraceptives, antacid powders, vitamin and mineral supplements and anti-acne preparations categories, among others, with several category-leading brands. Following the acquisition of Bharat Serums and Vaccines Limited, Mankind Pharma has further strengthened its leadership in the domestic women’s health segment. Mankind’s distribution network includes a robust field force of 17,700+ professionals, and a reach extending to over five lakh doctors across urban and rural markets. The company has 32 manufacturing facilities manufacturing a wide range of dosage forms, including tablets, capsules, syrups, vials, ampoules, blow fill seal, soft and hard gels, eye drops, creams, contraceptives and other over-the-counter products. Mankind has a consistent track record of product innovation through 6 dedicated R&D facilities backed by more than 730 scientists.
